You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動丨亞盛醫藥(06855.HK)收漲逾6% 與阿斯利康血液研發卓越中心Acerta製藥達成臨牀合作
格隆匯 06-24 16:11
格隆匯6月24日丨亞盛醫藥(06855.HK)收漲逾6%,報45港元,總市值94億港元。亞盛醫藥本週一發佈公告稱,公司與阿斯利康血液研發卓越中心Acerta製藥已達成一項臨牀研究合作。基於合作的條款,亞盛醫藥將支持其BCL-2選擇性抑制劑APG-2575與Acerta製藥的布魯頓酪氨酸蛋白激酶(BTK)抑制劑CALQUENCE®的聯合治療展開臨牀研究,以評估該聯合用藥在復發難治慢性淋巴細胞白血病(CLL)╱小淋巴細胞淋巴瘤(SLL)患者中的臨牀效果及安全性。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account